세계의 치주질환 치료 시장 : 치료 유형, 제품 유형, 환자 유형, 최종사용자별 - 예측(2025-2030년)

The Periodontal Disease Treatment Market was valued at USD 2.47 billion in 2024 and is projected to grow to USD 2.60 billion in 2025, with a CAGR of 5.49%, reaching USD 3.41 billion by 2030.

In today's rapidly evolving healthcare environment, periodontal disease treatment is witnessing significant advancements driven by innovative methodologies and emerging clinical practices. The market has undergone a substantial transformation as research and technological evolution converge to address both the clinical and patient-centric aspects of periodontal care. Modern treatment options now encompass a diverse range of therapies that seek to improve outcomes while minimizing patient discomfort and reducing long-term complications. This report provides a comprehensive overview of current market trends, highlighting the integration of advanced techniques, product innovations, and the increasing demand for both non-surgical and surgical interventions. As the prevalence of periodontal disease continues to rise globally, understanding these developments and the underlying factors influencing therapeutic choices becomes imperative for decision-makers and industry experts alike. The narrative that follows delves into transformative shifts, detailed segmentation insights, regional growth drivers, and key industry players shaping the market today. Through a balanced amalgamation of rigorous analysis and strategical foresight, this executive summary serves as a vital resource for stakeholders looking to navigate the complexities of periodontal disease management while capitalizing on future opportunities.

Transformative Shifts in the Periodontal Treatment Landscape

The periodontal disease treatment market is experiencing transformative shifts that underscore a broader trend towards patient-centric and technologically driven care. Innovations are not only reshaping traditional approaches but are also providing clinicians with improved tools and methodologies to manage complex periodontal conditions. Advances in diagnostic technologies, treatment planning, and digitally-assisted procedures have led to a paradigm shift in how practitioners approach both preventive care and active intervention. The introduction of high-precision laser treatments and minimally invasive surgical techniques has reduced patient recovery times while enhancing the overall treatment experience. Furthermore, evolving healthcare policies and an increased focus on preventive medicine are stimulating a robust demand for less invasive treatment options. As clinical research continues to highlight the efficacy of combining traditional scaling and root planning with cutting edge laser therapy, the market is witnessing an adaptive transformation that bridges scientific breakthroughs with real-world application. This strategic shift is further supported by interdisciplinary collaborations, driving a collective effort to redefine standards of care in periodontal treatment. The emphasis on evidence-based practice combined with a commitment to innovation has spurred significant restructuring within the market, urging both providers and industry leaders to reevaluate traditional treatment protocols in favor of more dynamic, results-oriented strategies.

Key Segmentation Insights in the Periodontal Treatment Market

A deep dive into market segmentation reveals a multifaceted approach that is instrumental in understanding the diverse needs of the periodontal treatment landscape. Insights derived from segmentation based on treatment type illustrate clear distinctions between non-surgical and surgical interventions. Under the non-surgical category, therapy is further refined through the application of antibiotics and antimicrobials, laser therapy, as well as scaling and root planing, which collectively form the cornerstone of conservative periodontal care. In parallel, surgical treatments-including bone grafting, flap surgery, and guided tissue regeneration-cater to more advanced cases where tissue repair and regeneration are paramount. Additionally, segmentation based on product type enhances this analysis by dividing the market into devices, medications, and regenerative materials. Specifically, devices encompass laser devices, scalers and cutters, as well as ultrasonic devices; medications cover the spectrum from antibiotics to antiseptic chips and non-steroidal anti-inflammatory drugs; and regenerative materials are typified by bone fillers, collagen membranes, and growth factors. The patient type segmentation further refines market analysis by differentiating between adult, geriatric, and pediatric patients, offering tailored insights into demographic-specific needs and trends. The segmentation by end-user refines this comprehensive view by capturing a broad spectrum of care settings that range from academic and research institutes to ambulatory surgical centers, dental clinics, homecare settings, and hospitals. Such a diversified segmentation framework is critical in understanding shifting demand patterns and anticipating the future trajectory of periodontal treatment innovations.

Based on Treatment Type, market is studied across Non-Surgical Treatment and Surgical Treatment. The Non-Surgical Treatment is further studied across Antibiotics & Antimicrobials, Laser Therapy, and Scaling & Root Planing. The Surgical Treatment is further studied across Bone Grafting, Flap Surgery, and Guided Tissue Regeneration.

Based on Product Type, market is studied across Devices, Medications, and Regenerative Materials. The Devices is further studied across Laser Devices, Scalers & Cutters, and Ultrasonic Devices. The Medications is further studied across Antibiotics, Antiseptic Chips, and Non-steroidal Anti-inflammatory Drugs. The Regenerative Materials is further studied across Bone Fillers, Collagen Membranes, and Growth Factors.

Based on Patient Type, market is studied across Adults, Geriatric, and Pediatric.

Based on End-User, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, Dental Clinics, Homecare Settings, and Hospitals.

Regional Dynamics Shaping the Global Market

The geographical landscape of the periodontal treatment market is characterized by distinct regional trends, each contributing uniquely to the overall market dynamics. In the Americas, robust healthcare infrastructure and a heightened emphasis on preventive oral care have driven significant market growth, setting high benchmarks in clinical excellence. In contrast, Europe, the Middle East, and Africa are marked by a blend of traditional practices and progressive treatment modalities where evolving regulatory frameworks and increasing investment in research and development are creating new opportunities. Meanwhile, the Asia-Pacific region is rapidly emerging as a critical player, with expanding urbanization, increasing awareness about dental health, and a burgeoning middle class fueling demand for advanced periodontal care. This regional diversity underscores the importance of tailoring strategies to meet local market needs while also leveraging global best practices. The interplay between established markets and emerging economies continues to define the competitive environment, offering nuanced insights into how demographic shifts, economic growth, and technological adoption collectively influence regional performance in periodontal disease treatment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights into Leading Industry Players

An in-depth look at the competitive landscape reveals a vibrant ecosystem of established and emerging companies that are driving innovation and setting industry standards in periodontal disease treatment. Prominent players such as 3M Company, ACTEON Group, Bausch Health Companies Inc., and Becton, Dickinson and Company are leading the way in product innovation and clinical excellence. Meanwhile, companies like BioHorizons, Inc. and Colgate-Palmolive Company have strengthened their market presence by integrating cutting-edge research with diversified product offerings. Other key contributors include Den-Mat Holdings, LLC, Dentsply Sirona Inc., and GC Corporation, who are noted for their commitment to enhancing patient outcomes through quality-driven solutions. Esteemed organizations such as Geistlich Pharma AG, GlaxoSmithKline plc, Haleon group, and Henry Schein, Inc. further complement the competitive matrix with robust portfolios and strategic market insights. Industry trailblazers like Ivoclar Vivadent AG, Johnson & Johnson, Kuraray Noritake Dental Inc., Lion Corporation, and Mectron S.p.A. continue to set benchmarks with innovative approaches, while the market dynamics are further enriched by the contributions of Patterson Companies, Inc., Pfizer Inc., Procter & Gamble Company, Septodont Holding SAS, Shofu Dental Corporation, Straumann Group, Sunstar Suisse SA, TePe Oral Health Care, Inc., Ultradent Products, Inc., VOCO GmbH, Water Pik, Inc., and Zimmer Biomet Dental. Collectively, this diverse group of companies fortifies the market with a blend of technological advancements, wide-ranging product portfolios, and unparalleled expertise in addressing the ever-evolving challenges of periodontal care.

The report delves into recent significant developments in the Periodontal Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ACTEON Group, Bausch Health Companies Inc., Becton, Dickinson and Company, BioHorizons, Inc., Colgate-Palmolive Company, Den-Mat Holdings, LLC, Dentsply Sirona Inc., GC Corporation, Geistlich Pharma AG, GlaxoSmithKline plc, Haleon group, Henry Schein, Inc., Ivoclar Vivadent AG, Johnson & Johnson, Kuraray Noritake Dental Inc., Lion Corporation, Mectron S.p.A., Patterson Companies, Inc., Pfizer Inc., Procter & Gamble Company, Septodont Holding SAS, Shofu Dental Corporation, Straumann Group, Sunstar Suisse SA, TePe Oral Health Care, Inc., Ultradent Products, Inc., VOCO GmbH, Water Pik, Inc., and Zimmer Biomet Dental. Actionable Recommendations for Industry Leaders

The evolving market trends in periodontal disease treatment underscore several strategic imperatives for industry leaders. A critical recommendation is to invest in continuous research and development to drive the discovery and adoption of innovative treatment protocols that not only enhance patient outcomes but also optimize clinical workflows. Leaders should consider leveraging data-driven insights to tailor their product and service offerings more effectively, ensuring that both non-surgical and surgical treatment options meet the nuanced demands of diverse patient demographics. Collaborations with academic and research institutions and strategic partnerships with technology providers can catalyze the integration of emerging therapies and digital health solutions into standard practice. Additionally, there is a growing need to prioritize educational initiatives that highlight the benefits and safe application of advanced periodontal treatments. This approach will help in building trust among healthcare providers and patients alike. Furthermore, streamlining regulatory compliance and reinforcing post-market data analytics can provide valuable feedback mechanisms, allowing companies to refine their products continually. Industry stakeholders are encouraged to harness these insights to create robust, scalable strategies that align with real-time market needs and future growth projections, thereby ensuring sustainable competitive advantage in a dynamic healthcare environment.

Conclusion: Steering Towards a Future of Innovation and Growth

In conclusion, the periodontal disease treatment market is undergoing a transformative phase characterized by technological innovations, dynamic segmentation strategies, and robust regional growth patterns. The integration of advanced treatment modalities, patient-specific strategies, and a wealth of clinical data has paved the way for significant advancements in both non-surgical and surgical periodontal care. Moreover, a detailed exploration of key regional trends and the competitive landscape underscores the critical importance of strategic collaborations, research investments, and market education. These elements are all essential in ensuring that providers not only meet current clinical challenges but also adapt to future opportunities. As industry players continue to push the envelope on treatment innovations and operational excellence, a forward-thinking approach is paramount to achieving sustainable growth and improved patient outcomes in periodontal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for cosmetic periodontal procedures globally
    • 5.1.1.2. Government and insurance incentives encouraging regular dental check-ups and periodontal care
  • 5.1.2. Restraints
    • 5.1.2.1. High treatment costs associated with periodontal disease
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing collaborative activities with academic institutions for innovation in periodontal disease treatment methods
    • 5.1.3.2. Integration of artificial intelligence in dental practices for personalized periodontal treatment plans
  • 5.1.4. Challenges
    • 5.1.4.1. Concern associated with intellectual property challenges and patent protections within the periodontal field
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment Type: Increasing adoption of non-surgical treatments due to their minimization of patient discomfort and faster recovery times
  • 5.2.2. Comparative analysis of periodontal treatment market: strategies targeting end-user segments in dental clinics, hospitals, and homecare settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Periodontal Disease Treatment Market, by Treatment Type

• 6.1. Introduction
• 6.2. Non-Surgical Treatment
  • 6.2.1. Antibiotics & Antimicrobials
  • 6.2.2. Laser Therapy
  • 6.2.3. Scaling & Root Planing
• 6.3. Surgical Treatment
  • 6.3.1. Bone Grafting
  • 6.3.2. Flap Surgery
  • 6.3.3. Guided Tissue Regeneration

7. Periodontal Disease Treatment Market, by Product Type

• 7.1. Introduction
• 7.2. Devices
  • 7.2.1. Laser Devices
  • 7.2.2. Scalers & Cutters
  • 7.2.3. Ultrasonic Devices
• 7.3. Medications
  • 7.3.1. Antibiotics
  • 7.3.2. Antiseptic Chips
  • 7.3.3. Non-steroidal Anti-inflammatory Drugs
• 7.4. Regenerative Materials
  • 7.4.1. Bone Fillers
  • 7.4.2. Collagen Membranes
  • 7.4.3. Growth Factors

8. Periodontal Disease Treatment Market, by Patient Type

• 8.1. Introduction
• 8.2. Adults
• 8.3. Geriatric
• 8.4. Pediatric

9. Periodontal Disease Treatment Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Ambulatory Surgical Centers
• 9.4. Dental Clinics
• 9.5. Homecare Settings
• 9.6. Hospitals

10. Americas Periodontal Disease Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Periodontal Disease Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Periodontal Disease Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. HuFriedyGroup unveils Sterify Gel's antibiotic-free mucoadhesive approach to periodontal healing
  • 13.3.2. Oral Biolife's newly announces Ambrilux Dental Gel
  • 13.3.3. The FDA's approval of the UW Department of Oral Health Sciences to study rapamycin
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. ACTEON Group
• 3. Bausch Health Companies Inc.
• 4. Becton, Dickinson and Company
• 5. BioHorizons, Inc.
• 6. Colgate-Palmolive Company
• 7. Den-Mat Holdings, LLC
• 8. Dentsply Sirona Inc.
• 9. GC Corporation
• 10. Geistlich Pharma AG
• 11. GlaxoSmithKline plc
• 12. Haleon group
• 13. Henry Schein, Inc.
• 14. Ivoclar Vivadent AG
• 15. Johnson & Johnson
• 16. Kuraray Noritake Dental Inc.
• 17. Lion Corporation
• 18. Mectron S.p.A.
• 19. Patterson Companies, Inc.
• 20. Pfizer Inc.
• 21. Procter & Gamble Company
• 22. Septodont Holding SAS
• 23. Shofu Dental Corporation
• 24. Straumann Group
• 25. Sunstar Suisse SA
• 26. TePe Oral Health Care, Inc.
• 27. Ultradent Products, Inc.
• 28. VOCO GmbH
• 29. Water Pik, Inc.
• 30. Zimmer Biomet Dental